Chronology 13F
← Back to convictions

KERYX BIOPHARMACEUTICALS INC

Unknown

2 whale investors · Q2 2018

Whale investors

Concentrated managers reporting this company in Q2 2018.

2 holders
  1. Abrams Capital ManagementDavid Abrams
    EquityQ2 2018
    $37.41M1.04% portfolio

Holdings reflect reported 13F data for Q2 2018 and may be delayed or incomplete.